These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38597168)

  • 1. Premix versus On-Demand Workflow Models in a Veterans Affairs Hematology/Oncology Pharmacy: Impact on Estimated Waste Costs and Patient Wait Time.
    Pan S; Gritte A; Malamakal J; Horowitz A; Harris A; Vig SJ
    J Pharm Pract; 2024 Oct; 37(5):1175-1182. PubMed ID: 38597168
    [No Abstract]   [Full Text] [Related]  

  • 2. Personnel time and preparation costs for compounded versus premixed intravenous admixtures in three community hospitals.
    Kirschenbaum BE; Cacace L; Anderson RJ; Ackerman LA
    Am J Hosp Pharm; 1988 Mar; 45(3):605-8. PubMed ID: 3369464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purchasing premixed products.
    Geberbauer CW
    J Healthc Mater Manage; 1988; 6(2):40, 42, 44-5. PubMed ID: 10286278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost analysis of mixing clindamycin and aminoglycosides.
    Abel SR; Olson SM
    Am J Hosp Pharm; 1987 Jun; 44(6):1385-7. PubMed ID: 3618617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leveraging advanced preparation of oncology medications: Decreasing turnaround-times in an outpatient infusion center.
    Blackmer J; Amoline K; Amancher J; Vogan E; Zimmer H; Borton M; Earl M; Boyd A
    J Oncol Pharm Pract; 2021 Sep; 27(6):1454-1460. PubMed ID: 32970518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variable cost per dose of preparing and administering small-volume cephalosporin admixtures. Veterans Administration Pharmacy Service Study Group.
    Am J Hosp Pharm; 1984 Dec; 41(12):2624-34. PubMed ID: 6517086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation and evaluation of a sterile compounding robot in a satellite oncology pharmacy.
    Bhakta SB; Colavecchia AC; Coffey W; Curlee DR; Garey KW
    Am J Health Syst Pharm; 2018 Jun; 75(11 Supplement 2):S51-S57. PubMed ID: 29802179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Drug Wastage in the Operating Rooms and Intensive Care Units of a Regional Health Service.
    Barbariol F; Deana C; Lucchese F; Cataldi G; Bassi F; Bove T; Vetrugno L; De Monte A
    Anesth Analg; 2021 May; 132(5):1450-1456. PubMed ID: 33667211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter study to evaluate the benefits of technology-assisted workflow on i.v. room efficiency, costs, and safety.
    Eckel SF; Higgins JP; Hess E; Cerbone T; Civiello JB; Conley C; Jafari N; Shah S; Speth SL; Thornton L
    Am J Health Syst Pharm; 2019 Jun; 76(12):895-901. PubMed ID: 31361850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of gentamicin premixed admixtures: cost and clinical utility.
    Zarowitz BJ; Owen H; Popovich J; Pancorbo S
    Hosp Pharm; 1987 Mar; 22(3):257-60. PubMed ID: 10311980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Lean Processes on Surgical Wait Times and Efficiency in a Tertiary Care Veterans Affairs Medical Center.
    Valsangkar NP; Eppstein AC; Lawson RA; Taylor AN
    JAMA Surg; 2017 Jan; 152(1):42-47. PubMed ID: 27603225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using lean methodology to improve productivity in a hospital oncology pharmacy.
    Sullivan P; Soefje S; Reinhart D; McGeary C; Cabie ED
    Am J Health Syst Pharm; 2014 Sep; 71(17):1491-8. PubMed ID: 25147174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic assessment of aseptic compounding rooms in hospital pharmacies in five European countries.
    Dekyndt B; Décaudin B; Lannoy D; Odou P
    J Oncol Pharm Pract; 2015 Apr; 21(2):102-10. PubMed ID: 24519187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation times and costs for various solutions used for continuous renal replacement therapy.
    Shaw AR; Chaijamorn W; Clark JS; Mueller BA
    Am J Health Syst Pharm; 2018 Jun; 75(11):808-815. PubMed ID: 29802114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personnel costs and preparation time in a centralized intravenous admixture program.
    Ryan DM; Daniels CE; Somani SM
    Am J Hosp Pharm; 1986 May; 43(5):1222-5. PubMed ID: 3087164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of a clinical pharmacist practitioner-led pharmacogenomics service in a Veterans Affairs hematology/oncology clinic.
    Dreischmeier E; Hecht H; Crocker E; Seckel E; Wilcox A; Fletcher C; Piccolo J
    Am J Health Syst Pharm; 2024 Sep; 81(19):e634-e639. PubMed ID: 38733328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specialist integrated haematological malignancy diagnostic services: an Activity Based Cost (ABC) analysis of a networked laboratory service model.
    Dalley C; Basarir H; Wright JG; Fernando M; Pearson D; Ward SE; Thokula P; Krishnankutty A; Wilson G; Dalton A; Talley P; Barnett D; Hughes D; Porter NR; Reilly JT; Snowden JA
    J Clin Pathol; 2015 Apr; 68(4):292-300. PubMed ID: 25631214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Standardized Infliximab Dose Rounding on an Outpatient Infusion Center.
    Park JJ; Boutillier L; Cruz JE; Joung G; Nemeth J
    J Manag Care Spec Pharm; 2018 Oct; 24(10):1028-1033. PubMed ID: 30247103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Costs of a cytostatic drug preparation unit in a hospital in Mexico].
    Martínez Rodríguez OA; Rivas Bocanegra RE; Ascencio-Pérez IS; Zapata Sánchez LA
    Farm Hosp; 2007; 31(6):375-8. PubMed ID: 18348668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic evaluation of access to musculoskeletal care: the case of waiting for total knee arthroplasty.
    Mather RC; Hug KT; Orlando LA; Watters TS; Koenig L; Nunley RM; Bolognesi MP
    BMC Musculoskelet Disord; 2014 Jan; 15():22. PubMed ID: 24438051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.